These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


644 related items for PubMed ID: 22320418

  • 1. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH, Gungel H, Altan C, Pasaoglu IB, Sabanci S.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [Abstract] [Full Text] [Related]

  • 2. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM, Stewart RH, Stewart WC, Jia G, Smugar SS, Galet VA.
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
    García Sanchez J.
    Eur J Ophthalmol; 2000 Aug; 10(3):198-204. PubMed ID: 11071026
    [Abstract] [Full Text] [Related]

  • 4. Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Cvenkel B, Stewart JA, Nelson LA, Stewart WC.
    Curr Eye Res; 2008 Feb; 33(2):163-8. PubMed ID: 18293187
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
    Konstas AG, Kozobolis VP, Tsironi S, Makridaki I, Efremova R, Stewart WC.
    Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
    [Abstract] [Full Text] [Related]

  • 6. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C, Oksüz H.
    Ophthalmic Res; 2007 Jan; 39(1):24-31. PubMed ID: 17164574
    [Abstract] [Full Text] [Related]

  • 7. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
    Konstas AG, Mikropoulos D, Dimopoulos AT, Moumtzis G, Nelson LA, Stewart WC.
    Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
    Pajic B, Pajic-Eggspuehler B, Häfliger IO.
    Curr Med Res Opin; 2010 Sep; 26(9):2213-9. PubMed ID: 20673200
    [Abstract] [Full Text] [Related]

  • 9. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC.
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC.
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [Abstract] [Full Text] [Related]

  • 11. Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.
    Konstas AG, Kozobolis VP, Lallos N, Christodoulakis E, Stewart JA, Stewart WC.
    Eye (Lond); 2004 Dec; 18(12):1264-9. PubMed ID: 15218522
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1999 Dec; 106(12 Suppl):10-6. PubMed ID: 10598692
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.
    Susanna R, Sheu WP, Latin American Glaucoma Society.
    Clin Ther; 2004 May; 26(5):755-68. PubMed ID: 15220019
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I, Harris A, Kagemann L, Siesky B, McCranor L.
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
    Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA, COSOPT versus XALATAN Study Groups.
    Acta Ophthalmol Scand; 2004 Feb; 82(1):42-8. PubMed ID: 14982045
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K, Snyder E, DuBiner H, Adamsons I.
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.
    Boyle JE, Ghosh K, Gieser DK, Adamsons IA.
    Ophthalmology; 1998 Oct; 105(10):1945-51. PubMed ID: 9787368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.